Entera Bio Ltd. (ENTX) is a clinical-stage biopharmaceutical company headquartered in Jerusalem, Israel, that is pioneering innovative oral delivery systems for large molecule therapeutics. Focusing on substantial unmet medical needs, the company leverages its proprietary platform to enhance patient compliance and broaden therapeutic options. Entera Bio's promising pipeline features advanced therapies designed to improve the efficacy and accessibility of treatments, thus positioning the company as a significant contributor to the advancement of biopharmaceuticals. With a commitment to revolutionizing healthcare solutions, Entera Bio is poised to transform therapeutic administration and patient outcomes.